These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2881861)
21. [H2 blockers in a new dosage form: effect on the endocrine system?]. Müller P; Dammann HG; Simon B Med Klin (Munich); 1986 Jan; 81(2):45-8. PubMed ID: 2878357 [No Abstract] [Full Text] [Related]
22. [Clinical concept of acute and chronic peptic ulcers]. Oshiba S; Asada S Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):27-30. PubMed ID: 1673702 [No Abstract] [Full Text] [Related]
23. Surgery for peptic ulcer disease in the era of H2 receptor blockers. Jamieson GG Dig Dis; 1989; 7(2):76-85. PubMed ID: 2566402 [No Abstract] [Full Text] [Related]
24. [Peptic ulcer: how to treat it long term]. Zaterka S; Bettarello A Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(1):1-3. PubMed ID: 2892245 [No Abstract] [Full Text] [Related]
25. [Opinion on the drug treatment of peptic ulcer]. Tarpila S Duodecim; 1991; 107(22):1906-7. PubMed ID: 1365972 [No Abstract] [Full Text] [Related]
27. [The histoenzymological and ultrastructural changes in the gastric mucosa in peptic ulcer after treatment with pirenzepine and histamine H2-receptor blockaders]. Degtiareva II; Kharchenko NV; Lodianaia EV; Zukheĭr Kh; Tokar' DV; Nevstruev VP; Piletskiĭ AM Lik Sprava; 1995; (1-2):48-51. PubMed ID: 7483543 [TBL] [Abstract][Full Text] [Related]
28. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists]. Hentschel E Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397 [No Abstract] [Full Text] [Related]
29. Pharmacology update. Anti-peptic ulcer agents--Part I. A histamine 2 receptor antagonist. Romankiewicz JA J Pract Nurs; 1981 Jan; 31(1):15-6. PubMed ID: 6108367 [No Abstract] [Full Text] [Related]
30. Drug therapy of peptic ulcer disease. Ching CK; Lam SK Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483 [TBL] [Abstract][Full Text] [Related]
31. [Follow-up studies of the tissue healing process in peptic ulcer; clinicopathological study of recurrence refractory conditions in peptic ulcer]. Saito Y; Kato T; Niwa M; Ogoshi K; Tsunoda H Nihon Rinsho; 1988 Jan; 46(1):94-7. PubMed ID: 2897488 [No Abstract] [Full Text] [Related]
32. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2). Feldman M; Burton ME N Engl J Med; 1990 Dec; 323(25):1749-55. PubMed ID: 1978926 [No Abstract] [Full Text] [Related]
33. [Surgery of peptic ulcer 10 years after the introduction of anti-H2 agents]. Bartolotta M; Carditello A Ann Gastroenterol Hepatol (Paris); 1988; 24(3):107-9. PubMed ID: 2899990 [TBL] [Abstract][Full Text] [Related]
35. [Ulcer surgery before and after administration of H2 blockader treatment]. Christensen A; Bousfield R Ugeskr Laeger; 1987 Oct; 149(43):2895-7. PubMed ID: 2893482 [No Abstract] [Full Text] [Related]
36. Acid reduction in peptic ulcer disease. Choosing therapy according to drug interactions, individual response, and cost. Parent K Postgrad Med; 1994 Nov; 96(6):53-9. PubMed ID: 7971612 [TBL] [Abstract][Full Text] [Related]
37. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings]. Gostishchev VK; Evseev MA Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681 [TBL] [Abstract][Full Text] [Related]
38. Satellite symposium: New therapeutic approach to peptic ulcer disease. 34th annual meeting of the Japanese Society of Gastroenterology. Gastroenterol Jpn; 1993 May; 28 Suppl 5():191-201. PubMed ID: 8103024 [No Abstract] [Full Text] [Related]
39. Surgical treatment of peptic ulcer disease before and after introduction of H2 blockers. Scheeres DE; DeKryger LL; Dean RE Am Surg; 1987 Jul; 53(7):392-5. PubMed ID: 2886084 [TBL] [Abstract][Full Text] [Related]
40. Advances in the treatment of peptic ulcer disease. Camara DS Compr Ther; 1987 Aug; 13(8):13-6. PubMed ID: 2887333 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]